Search
for
Sort by
Research 30 of 1000+
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept
- [Hidradenitis suppurativa - symptoms, diagnostics, and therapy].
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Psoriasis and Alopecia: Unveiling the Links
- Scalp Psoriasis
- Alopecia areata: a new treatment plan
- Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppura
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections
- Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
- Alopecia Areata following Adalimumab
- Supplementary material for: Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
- The Roles of Keratinocytes in the Initiation, Progression and Maintenance of Hidradenitis Suppurativa
- TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Cutaneous drug reactions
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- COVID-19 and Sex Differences
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological medication effects on male fertility
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Novel therapies for alopecia areata: The era of rational drug development
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case